UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 60 filers reported holding UROGEN PHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $148,542 | +17.1% | 16,076 | +12.4% | 0.00% | – |
Q4 2022 | $126,841 | -78.6% | 14,300 | -13.2% | 0.00% | -100.0% |
Q2 2019 | $592,000 | -91.0% | 16,484 | -90.8% | 0.00% | -92.0% |
Q1 2019 | $6,612,000 | +28.2% | 178,996 | +49.5% | 0.02% | +8.7% |
Q4 2018 | $5,156,000 | +2.4% | 119,736 | +12.4% | 0.02% | +27.8% |
Q3 2018 | $5,033,000 | +378.9% | 106,548 | +404.2% | 0.02% | +350.0% |
Q2 2018 | $1,051,000 | – | 21,132 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |